Cargando…
Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
Poziotinib is an orally active, irreversible, pan-HER tyrosine kinase inhibitor used to treat non-small cell lung cancer, breast cancer, and gastric cancer. Poziotinib is currently under clinical investigation, and understanding its drug-drug interactions is extremely important for its future develo...
Autores principales: | Wang, Jinhui, Chen, Feifei, Jiang, Hui, Xu, Jia, Meng, Deru, Geng, Peiwu, Dai, Dapeng, Hu, Jingbo, Zhou, Yunfang, Zhou, Quan, Wang, Shuanghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970697/ https://www.ncbi.nlm.nih.gov/pubmed/33746741 http://dx.doi.org/10.3389/fphar.2020.593518 |
Ejemplares similares
-
Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
por: Ji, Weiping, et al.
Publicado: (2021) -
Inhibitory Effect of Lygodium Root on the Cytochrome P450 3A Enzyme in vitro and in vivo
por: Zhou, Yunfang, et al.
Publicado: (2020) -
Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC‐MS/MS
por: Wang, Shuanghu, et al.
Publicado: (2023) -
Inhibitory Effect of Imperatorin on the Pharmacokinetics of Diazepam In Vitro and In Vivo
por: Zhou, Yunfang, et al.
Publicado: (2020) -
Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats
por: Shi, Yong, et al.
Publicado: (2021)